EGEIRO Pharma Quote - ALVET

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.124

Bid

0.08

Offer

0.13

Volume

481,797

0.0666 Day's Range 0.124

0.0632 52 Week Range 1.55

Market Cap

399.768k

Previous Close

0.078

Open

0.0666

Last Trade

10000

0.124

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

28,610

Shares Outstanding

3,223,936

Dividend Yield

PE Ratio

-0.25

Earnings Per Share (EPS)

-0.49

Revenue

315k

Net Profit

-1.57M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.thera.vet

Headquarters

Charleroi, Hainaut, Bel

Founded

EGEIRO Pharma is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALVET. The last closing price for EGEIRO Pharma was 0.08 €. Over the last year, EGEIRO Pharma shares have traded in a share price range of 0.0632 € to 1.55 €.

EGEIRO Pharma currently has 3,223,936 shares in issue. The market capitalisation of EGEIRO Pharma is 251,467.01 € . EGEIRO Pharma has a price to earnings ratio (PE ratio) of -0.25.

Le Conseil d'administration d’EGEIRO prend acte de la démission de Enrico Bastianelli et modifie sa gouvernance

Regulatory News: EGEIRO Pharma (code ISIN : BE0974387194 - mnémonique : ALVET), société biopharmaceutique spécialisée dans le repositionnement et la reformulation de médicaments existants...

TheraVet devient EGEIRO Pharma

Compte-rendu de l’Assemblée Générale Extraordinaire de TheraVet du 28 octobre 2024 Regulatory News: TheraVet (ISIN : BE0974387194 - ticker : ALVET), société de biotechnologie pionnière dans le...

TheraVet : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la loi du 02 mai 2007)

Regulatory News: TheraVet (code ISIN : BE0974387194 - mnémonique : ALVET), société de biotechnologie spécialisée dans les traitements ostéoarticulaires en santé animale, publie le nombre...

TheraVet Announces a Strategic Transformation Project Aimed at Creating a Leader in Human Idiopathic Pulmonary Fibrosis

Operation aimed at replacing TheraVet's veterinary activities with a high potential biotech program linked to the repositioning of an innovative molecule in idiopathic pulmonary fibrosis;...

TheraVet annonce la réalisation de 2 augmentations de capital à la suite de la conversion d’obligations convertibles à hauteur de 135 000€

Regulatory News: TheraVet (ISIN : BE0974387194 - ticker : ALVET), société de biotechnologie pionnière dans le traitement des maladies ostéoarticulaires des animaux de compagnie, annonce la...

TheraVet Reports Its 2024 Half-year Results and Provides an Update on the Development of Its Activities

Number of BIOCERA-VET kits sold increased by 19% compared to the 1st half of 2023, and by 72% in the 2nd quarter of 2024 compared to 2nd quarter 2023 Net sales increase by 12.1%1 compared to the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.054	77.1428571429	0.07	0.124	0.0632	89821	0.08771393	DE
4	0.0175	16.4319248826	0.1065	0.124	0.0632	28318	0.08777482	DE
12	-0.0755	-37.8446115288	0.1995	0.205	0.0632	28610	0.11386739	DE
26	-0.474	-79.2642140468	0.598	0.606	0.0632	21119	0.18045628	DE
52	-1.356	-91.6216216216	1.48	1.55	0.0632	14079	0.38338881	DE
156	-5.916	-97.9470198675	6.04	6.46	0.0632	7152	1.34942183	DE
260	-7.676	-98.4102564103	7.8	8.56	0.0632	6754	1.78806851	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALCYBCybergun	0.0002 € (100.00%)	10.06M
ALVETEGEIRO Pharma	0.124 € (58.97%)	481.8k
ALDVAlliance Developpement Capital Siic	0.074 € (32.14%)	6k
MLSRPSpeed Rabbit Pizza	8.20 € (30.16%)	19
MLSEQSequa Petroleum NV	0.011 € (29.41%)	12k
MLCOTCoretech 5	0.01 € (-41.18%)	200
ATOAtos SE	0.495 € (-32.65%)	17.92M
AFMEAffluent Medical	1.20 € (-21.05%)	21.92k
ALBIOBiosynex	2.095 € (-18.32%)	26.9k
TRACTTeract SA	1.03 € (-15.23%)	76.91k
BCPBanco Comercial Portugues SA	0.4457 € (2.20%)	44.64M
ALNEVNeovacs	0.0003 € (0.00%)	33.59M
ATOAtos SE	0.495 € (-32.65%)	17.92M
ALCYBCybergun	0.0002 € (100.00%)	10.06M
ORAOrange.	9.706 € (-2.99%)	9.65M